Diabetes Research and Clinical Practice
Volume 64, Issue 1 , Pages 71-72, April 2004

Sandostatin LAR for cystoid diabetic macular edema: a 1-year experience

  • Maria Concepcion Hernaez-Ortega

      Affiliations

    • European Innovative Biomedicine Institute (EIBI), C/Jardines 2, 1-G, 39700 Cantabria, Spain
    • Department of Ophthalmology, Hospital of Cruces, Vizcaya, Spain
    • Corresponding Author InformationCorresponding author. Tel.: +34-609409113.
    • ,
  • Enrique Soto-Pedre

      Affiliations

    • European Innovative Biomedicine Institute (EIBI), C/Jardines 2, 1-G, 39700 Cantabria, Spain
    • ,
  • Juan Jose Beitia Martin

      Affiliations

    • Endocrinology Section, Hospital of Galdacano, Vizcaya, Spain

Received 8 July 2003; received in revised form 3 October 2003; accepted 7 October 2003.

Abstract 

We report the clinical outcome of a 46-year-old diabetic patient with cystoid macular edema treated with Sandostatin® long-acting release (LAR). Because cystoid changes in both eyes were refractive to conventional treatment (i.e., vitrectomy and periocular steroids), the patient was treated with Sandostatin® LAR® 20mg every four weeks. One year later the patient maintained corrected visual acuity of 20/40 in the right eye and 20/100 in the left eye, the cystoid changes had disappeared in the right eye and had greatly decreased in the left eye. In addition, the intraocular pressure had declined and no other complications were found. Thus, Sandostatin® LAR® may be considered for the treatment of diabetic patients with cystoid macular edema.

Keywords: Diabetes mellitus, Diabetic retinopathy, Cystoid macular edema, Somatostatin

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.
 

PII: S0168-8227(03)00263-8

doi:10.1016/j.diabres.2003.10.003

Diabetes Research and Clinical Practice
Volume 64, Issue 1 , Pages 71-72, April 2004

Article Tools